Lasofoxifene Effective for Dyspareunia
May 10th 2005Dyspareunia is a significant problem in postmenopausal women. A recent study at George Washington University found that up to 92% of sexually active women reported moderate or severe symptoms. Forty percent of women cited dyspareunia as their most bothersome problem associated with vaginal atrophy. A recent Phase III trial showed that lasofoxifene can significantly improve the symptoms of dyspareunia as well as increase bone mineral density (BMD) in postmenopausal women.
Earlier is Better in Prenatal Diagnosis
May 10th 2005There is no such thing as too early when it comes to prenatal screening and diagnosis of chromosomal abnormalities. For women under 35, the American College of Obstetricians and Gynecologists (ACOG) has long recommended noninvasive screening in the second trimester. For older women, chorionic villus sampling (CVS) or amniocentesis were typically recommended, although these invasive procedures are now offered to women of any age during the second trimester.
Preterm Delivery A Heritable Trait
May 10th 2005Analysis of preterm delivery (PTD) patterns among Mormon women in Utah and surrounding states indicates that genetics play a leading role in preterm delivery. If the genetic link holds, obstetricians can expect to see even higher rates of PTD in future years.
Lasofoxifene Effective for Dyspareunia
May 10th 2005Dyspareunia is a significant problem in postmenopausal women. A recent study at George Washington University found that up to 92% of sexually active women reported moderate or severe symptoms. Forty percent of women cited dyspareunia as their most bothersome problem associated with vaginal atrophy. A recent Phase III trial showed that lasofoxifene can significantly improve the symptoms of dyspareunia as well as increase bone mineral density (BMD) in postmenopausal women.
Fewer Pap Tests More Cost-Effective for Some Middle-Aged Women
May 10th 2005Many middle-aged women are getting more Pap tests than they need. Women aged 45 to 60 are typically advised to get an annual Pap test, noted George Sawaya, MD, Associate Professor of Obstetrics, Gynecology, and Reproductive Science at the University of California San Francisco. But in a paper presented yesterday, Dr. Sawaya concluded that women with a history of three or more normal Paps should only be screened once every 3 years.
Triplet Ultrasound Growth Curves Mapped
May 10th 2005The identification of abnormal growth in triplet fetuses has been difficult because there have been no standards for comparison. A study at Tufts-New England Medical Center in Boston has produced curves for growth as measured by estimated fetal weight, abdominal circumference, biparietal diameter, head circumference, and femur length. All measurements were conducted sonographically.
Invitation to Gyn Exam Effective
May 10th 2005Do even half of your patients keep their appointments for annual gynecologic exams? Compliance with annual checkups is so poor that most ob/gyns would have to answer "no." Boris Petrikovsky, MD, PhD, and a research team at Nassau University Medical Center in East Meadow, NY, found that simply inviting women to visit their physician can boost compliance rates by nearly a third.
Meeting Preview: Monday, May 9, 2005
May 8th 2005The ACM got off to a strong start at 8:30 am with the opening ceremony and first scientific session, better known as the President's Program. This year's program focuses on Sex, Power, and Politics. Malcolm Potts, MB, BChir, PhD, FRCOG, leads off with the Samuel A. Cosgrove Memorial Lecture, asking the provocative question "Why Can't a Man Be More Like a Woman? The Behavioral Background of Ob-Gyn Practice."
San Francisco hosts annual ACOG meeting
May 8th 2005The American College of Obstetricians and Gynecologists brings its Annual Clinical Meeting back to San Francisco's Moscone Convention Center for 2005. The City by the Bay has long been one of ACOGs's most popular venues, said president Vivian Dickerson, MD, in her official welcome message on the College's Web site. The 2005 clinical meeting is no exception.
Ovarian aging: Is there a "norm"?
May 1st 2005Some women appear to have a gradual, yet premature, decline in ovarian function that is distinct from ovarian failure. In the author's experience, there is hope for successful pregnancy in these cases, with quick and correct diagnosis and the right treatment.
Editorial: Preventing VTE: Part 3-the pregnant patient
May 1st 2005My first two editorials on venous thromboembolism (VTE) suggested ways to reduce risk in women taking estrogen-containing hormones and undergoing gynecologic surgery, respectively. This editorial explores strategies for avoiding it in pregnancy.
Case Studies in Coding: Coding for colpopexy
May 1st 2005Each year CPT introduces new codes and makes revisions to existingcodes to better reflect current medical practices. CPT 2005 is nodifferent. This month, we'll look at changes in coding for vaginalcolpopexy. The 2005 CPT codes reflect the expansion and improvementof surgical techniques in the area of female reconstructive surgery
Is there a link between ovulation induction and cancer?
May 1st 2005Although there have been no clinical trials to conclusively establish a cause-and-effect relationship between ovulation induction with clomiphene citrate or gonadotropins and cancer, evidence derived from prospective and cohort studies suggests the following:
What maternal smoking does to fetal chromosomes
May 1st 2005A fetus is more likely to have chromosomal instability, expressed as an increase in structural chromosomal abnormalities and chromosomal lesions, when a woman smokes 10 or more cigarettes a day for at least 10 years and continues to smoke during pregnancy. And that danger is not influenced by maternal age.
BRCA mutations just as prevalent in DCIS as in invasive breast cancer
May 1st 2005Women with BRCA1 and BRCA2 mutations are not only at greater risk for invasive breast cancer (IBC); the latest research suggests these mutations also increase the threat of ductal carcinoma in situ (DCIS), according to a case-control study conducted in Connecticut.
SSRIs during pregnancy may cause neonatal withdrawal syndrome
May 1st 2005The risks of neonatal convulsions and neonatal withdrawal syndrome seem to increase when a pregnant women uses selective serotonin reuptake inhibitors (SSRIs), with paroxetine being the worst offender, according to cases reported by 72 countries to the World Health Organization's Collaborating Centre for International Drug Monitoring in Uppsala, Sweden.